Acacia Pharma

About:

Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.

Website: http://www.acaciapharma.com

Top Investors: Hercules Capital, F-Prime Capital, Novo Holdings, Eight Roads Ventures, Gilde Healthcare

Description:

Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.

Total Funding Amount:

$63.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2006-01-01

Founders:

Julian Gilbert, Robert Gristwood

Number of Employees:

51-100

Last Funding Date:

2018-07-02

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai